The profile of autoimmunity in Type 1 diabetes patients

被引:6
|
作者
Derrou, Sara [1 ,2 ]
El Guendouz, Faycal [1 ,2 ]
Benabdelfedil, Yousra [1 ,2 ]
Chakri, Imad [3 ]
Ouleghzal, Hassan [1 ,2 ]
Safi, Somaya [1 ,2 ]
机构
[1] Mil Hosp Moulay Ismail, Dept Endocrinol Diabetol & Nutr, Meknes, Morocco
[2] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Fes, Morocco
[3] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Dept Clin Res & Community Hlth Lab, Fes, Morocco
关键词
Autoimmunity; celiac disease; thyroiditis; type; 1; diabetes; CELIAC-DISEASE; THYROID AUTOIMMUNITY; CLINICAL PROFILE; IMMUNE-RESPONSE; CHILDREN; ADOLESCENTS; PREVALENCE; MELLITUS; AUTOANTIBODIES; CELL;
D O I
10.4103/aam.aam_8_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by pancreatic beta-cells destruction. Anti-pancreatic antibodies are the witness of beta-cell destruction and their dosage is mainly used for etiological diagnosis. Patients with T1DM are at increased risk of developing other autoimmune reactions, which may involve other organs, resulting in organ specific autoimmune disease. The most frequently encountered are autoimmune thyroid disease, followed by celiac and gastric disease and other rare autoimmune diseases. Objectives: The purpose of this study is to investigate the prevalence of autoimmune markers in patients with T1DM. Methods: The study was conducted at the Department of Endocrinology of the Military Hospital Moulay Ismail in Meknes Morocco, from January 2016 to December 2018. All Type 1 diabetes patients consulting during the study period were included in the study. Their clinical and biochemical data were collected at their first presentation, made up of anti-pancreatic antibodies (glutamic acid decarboxylase [GAD] antibody, tyrosine phosphatase antibody, and islet cell antibody) and other organ-specific antibodies: the thyroid (antithyroid peroxidase antibody, antithyroglobulin antibody, and antithyroid-stimulating hormone receptor antibody), the intestine (IgA antitissue transglutaminase antibody), the adrenal gland (anti-21 hydroxylase antibody), and the stomach (antigastric parietal cell antibody and anti-intrinsic factor antibody). Results: Fifty-four patients were included, with an average age of 26 years. GAD, tyrosine phosphatase, and islet cell antibodies were detected in 74%, 22%, and 3.7%, respectively, of the 54 patients examined. The prevalence of extrapancreatic autoimmunity was 45% with a large preponderance among different immunities of those from thyroid and celiac diseases (CDs). Conclusion: Our results confirm that patients with Type 1 diabetes should be investigated for the presence of autoimmune diseases mainly from thyroid and CDs.
引用
收藏
页码:19 / 23
页数:5
相关论文
共 50 条
  • [21] Prevalence of Organ-Specific Autoimmunity in Patients With Type 1 Diabetes Mellitus
    Alam, Ahmad
    Singh, Surya K.
    Kumar, Ritesh
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [22] Risk lipoprotein profile in patients with type 1 diabetes mellitus
    Miguel-Soca, P. E.
    Corella-del Toro, I.
    [J]. ANALES DE PEDIATRIA, 2013, 79 (05): : 335 - 336
  • [23] Autoimmunity in Patients with Type 2 Diabetes in Newfoundland and Labrador
    Iqbal, Sahar J.
    [J]. DIABETES, 2018, 67
  • [24] Islet autoimmunity in phenotypic type 2 diabetes patients
    Brooks-Worrell, B.
    Narla, R.
    Palmer, J. P.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 : 137 - 140
  • [25] Autoimmunity to tetraspanin-7 in type 1 diabetes
    McLaughlin, Kerry A.
    Tombs, Melissa A.
    Christie, Michael R.
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2020, 209 (04) : 437 - 445
  • [26] Adrenal Autoimmunity in Pediatric Subjects with Type 1 Diabetes
    Tiwari, Rishita
    Brenner, Dennis
    Reiter, Edward
    Dunbar, Nancy
    Allen, Holley
    [J]. DIABETES, 2009, 58 : A323 - A323
  • [27] Possible involvement of autoimmunity in fulminant type 1 diabetes
    Oikawa, Yoichi
    Shimada, Akira
    [J]. DIABETOLOGY INTERNATIONAL, 2020, 11 (04) : 329 - 335
  • [28] The environment and the origins of islet autoimmunity and Type 1 diabetes
    Regnell, S. Eringsmark
    Lernmark, A.
    [J]. DIABETIC MEDICINE, 2013, 30 (02) : 155 - 160
  • [29] Characterization of Autoimmunity in the Acceleration of Atherosclerosis in Type 1 Diabetes
    Park, Kyoungmin
    Li, Qian
    Park, Hyunseok
    St-Louis, Ronald
    Fu, Jialin
    Rask-Madsen, Christian
    Maddaloni, Ernesto
    Yokomizo, Hisashi
    Kissler, Stephan
    Lichtman, Andrew H.
    King, George L.
    [J]. DIABETES, 2020, 69
  • [30] Possible involvement of autoimmunity in fulminant type 1 diabetes
    Yoichi Oikawa
    Akira Shimada
    [J]. Diabetology International, 2020, 11 : 329 - 335